Qiansong Cheng Jing Wang Chenglan Lv Jingyan Xu
10.2147/OTT.S309408
Onco Targets Ther
2021 May 24;14:3367-3372.
bruton’s tyrosine kinase primary central nervous system lymphoma targeted therapy zanubrutinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34079282/
Case Reports
PMC8163630
34079282
Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib
2021